HERPES VIRUS (HHV 2) - ANVISA Registration 10339840513
Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840513 and manufactured by DIASORIN MOLECULAR LLC. The registration is held by DIASORIN LTDA with validity until Sep 02, 2029.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including DIASORIN ITALIA S.P.A., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10339840513
25351810151201857
01896764000170
Company Information
Dates and Status
Sep 02, 2019
02/09/2029
09/18/2025 19:00:01
HERPES VÍRUS (HHV 2)
Família MAGLUMI HSV-2 de IgM (CLIA)
Not specified
80102513478
Jul 14, 2025
HERPES VÍRUS (HHV 2)
Família MAGLUMI HSV-2 de IgM (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513478
Jul 14, 2025
HERPES VÍRUS (HHV 2)
Familia MAGLUMI IgG de HSV-2 (CLIA)
Not specified
80102513482
Jul 14, 2025
HERPES VÍRUS (HHV 2)
Familia MAGLUMI IgG de HSV-2 (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513482
Jul 14, 2025
HERPES VÍRUS (HHV 2)
Micropartículas de HSV-2 IgM (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513380
Feb 24, 2025

